How Rising Autoimmune Disease Prevalence and Targeted Therapy Development Are Driving the Global Ahsa1 Antibody Market
The global Ahsa1 Antibody market is expanding as pharmaceutical companies, research institutions, and diagnostic laboratories invest in advanced antibody technologies to support therapeutic development, research applications, and diagnostic solutions. The market was valued at USD 500 million in 2024 and is projected to reach USD 1,500 million by 2035, growing at a CAGR of 10.6%. The Ahsa1...
0 Comentários 0 Compartilhamentos 285 Visualizações 0 Anterior